Ireland· IE-PA-PA1436/002/002

Co-amoxiclav Bluefish 500 mg/125 mg film- coated tablets

A amoxicillin und beta-lactamase-inhibitor product containing clavulanic acid + amoxicillin trihydrate, registered in Ireland by Bluefish Pharmaceuticals AB. The same ATC class is registered in 13 of our 19 countries.

ATC J01CR02

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about clavulanic acid + amoxicillin trihydrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Amoxicillin und beta-lactamase-inhibitor is registered in 13 of 19 countries.

Countries holding a registration under ATC J01CR02 (amoxicillin und beta-lactamase-inhibitor), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search amoxicillin und beta-lactamase-inhibitor products by name

Amoxicillin und beta-lactamase-inhibitor · ATC J01CR02

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of amoxicillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.28 in Italy to $5.60 in Switzerland — a ×4.4 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Amoxicillin und beta-lactamase-inhibitor · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

CH Switzerland$5.60
ES Spain$4.65
CZ Czechia$1.42
IT Italy$1.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Clavulanic acid + Amoxicillin trihydrate
Manufacturer: Bluefish Pharmaceuticals AB
Country: Ireland (IE)
ATC code: J01CR02
ATC class: Amoxicillin und Beta-Lactamase-Inhibitor
Defined daily dose: 1.5 g, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA1436/002/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for amoxicillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check amoxicillin und beta-lactamase-inhibitor against other medicines How interaction checks work

Amoxicillin und beta-lactamase-inhibitor · interactions on record

24 records

4 severe
17 moderate

Most severe, free to view

LeflunomidL04AA13severe
TeriflunomidL04AA31severe
LeflunomideL04AK01severe
TeriflunomideL04AK02severe

3 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Amoxicillin und beta-lactamase-inhibitor in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All amoxicillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Amcladoz, Amclavu
Belgium · Amoclane, Amoclaneeg
Bulgaria · Amoksiklav Es, Aмоксигамма
Cyprus · Augmentin, Augmentin Es
Czechia · Amoksiklav, Amoxicillin/Clavulanic Acid Aptapharma
Germany · Amoclan, Amoclav
Denmark · Amoxicillin/Clavulansyre Aurobindo, Baxumil
Estonia · Amoksiklav, Amoxicillin/Clavulanic Acid Auxilia
Spain · Amoxicilina / Ácido Clavulánico Pensa Pharma, Amoxicilina/Ácido Clavulánico Almus
Finland · Amorion Comp, Amoxicillin/Clavulanic Acid Bioglan
France · Amoxicillin / Clavulanic Acid Reig Jofre, Amoxicillin/Acide Clavulanique Zydus France
United Kingdom (Northern Ireland) · Augmentin, Augmentin Duo
Greece · Augmentin, Augmentin Mf (Γεύση Φρούτων)
Croatia · Amoksicilin/Klavulanska Kiselina Antibiotice, Amoksicilin/Klavulanska Kiselina Aptapharma
Hungary · Aksolin, Aktil
Iceland · Amoxicillin/Clavulanic Acid Normon, Spectracillin
Italy · Abba, Abioclav
Lithuania · Amoksiklav, Amoxicillin/Clavulanic Acid Antibiotice
Luxembourg · Amoclane, Amoxiclav
Latvia · Amoksiklav, Amoxicillin/Clavulanic Acid
Malta · Amoxi-Clavulan, Amoxicillin/Clavulanic Acid Aptapharma
Netherlands · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicilline/Clavulaanzuur
Norway · Augmentin, Augmentin Blandet Fruktsmak
Poland · Amoclan, Amoksiklav
Portugal · Agmalife, Agmalife Bid
Romania · Amoksiklav, Amoksiklav Quicktab
Sweden · Amoxicillin/Clavulanic Acid Aurobindo, Amoxicillin/Clavulanic Acid Bb
Slovenia · Amoksicilin/Klavulanska Kislina Antibiotice, Amoksicilin/Klavulanska Kislina Aptapharma
Slovakia · Amoksiklav, Amoksiklav 2 X

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fc0474d0-7362-4ec6-88ff-5112956788ab
GET /v1/drugs/fc0474d0-7362-4ec6-88ff-5112956788ab?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01CR",
    "J01CR02"
  ],
  "strength": null,
  "pa_number": "PA1436/002/002",
  "substances": [
    "Clavulanic acid",
    "Amoxicillin trihydrate"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "06/11/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0037-073-003"
}

API reference MCP server Plans

See everything about amoxicillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console